Evidence shows that effective prevention programs for people who use drugs can reduce transmission of HIV and hepatitis B (HBV), and other harms related to drug use. Harm reduction programs, like needle and syringe programs, lead to fewer people having HIV and less needle and equipment reuse, and are cost effective. EENet had developed a Research Report Round-up of a report that offers best practice recommendations to improve the effectiveness of harm reduction programs that deliver prevention services to people who use drugs and are at risk of HIV, hepatitis B, and hepatitis C, and other harms.
You can read this Research Report Round-up on the EENet website.
Research Report Round-ups are brief summaries of research reports, presented in a user-friendly format. To read EENet’s clear language report summaries, visit www.eenet.ca.